Clin2
NCT04713670Possibly a fitRecruiting

Tested medicines to cure new H. pylori infection

H. Pylori Infection

Part of Digestive system, Infections clinical trials.

This trial compares different stomach-medicine combinations to eliminate a new (first-time) H. pylori infection. It may help find the most effective treatment approach for people who have never tried eradication therapy before.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
1,200 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You have a new H. pylori infection (you have never been treated to clear it before).
  • You are over 20 years old.
  • You have not had the stomach surgery called total or subtotal gastrectomy.
  • You do not have serious long-term illness like end-stage kidney disease, liver cirrhosis, or cancer that can’t be cured.
  • You are not pregnant or breastfeeding.
  • You can safely take the study medicines and have no past serious allergy to them.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012785Not yet recruiting
Brewer's yeast and minocycline for new H. pylori patients

This trial tests a treatment combining a probiotic (Saccharomyces boulardii) with an antibiotic (minocycline) for people who have never been treated for H. pylori infection. It aims to see if this combination works well and is safe.

Nanjing, Jiangsu
NCT07344506Recruiting· Phase 4
Cure H. pylori: New combination therapy for stomach infection

This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.

Karachi
NCT05332444Recruiting· Phase 4
Check if stomach-bacteria testing improves rescue treatment for H. pylori

This study compares two ways to treat Helicobacter pylori (H. pylori) infection that didn’t go away with prior therapy. One approach uses test results to guide which medicines to use, and the other uses standard (“empiric”) treatment. The goal is to see which works better and more safely as a rescue plan.

Taipei
NCT07068607Recruiting· Phase 4
Comparing two treatments for H. pylori infection

This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.

Xi'an, Shaanxi
NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT07232095Recruiting· Phase 4
7-Day treatment for H. pylori with new acid blocker and antibiotics

This trial tests a 7-day combination of vonoprazan, high-dose amoxicillin, and bismuth to treat Helicobacter pylori infection in people who have never been treated for it before. The goal is to see if this short course is effective and safe for curing the infection.

Nanjing, Jiangsu

Hear when a new H. Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.